At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top The Netherlands based CFO’ operating in the Pharmaceutical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Fred Dom
Chief Financial Officer of HiFiBiO
Fred Dom is a Co-founder of HiFiBiO Inc. and he now serves as the HiFiBiO Therapeutics Chief Financial Officer and Director of French Operations. Mr. Dom is a serial entrepreneur with expertise in private capital investment and operations. Previously, he was CEO of FlexGen (Leiden, the Netherlands) where he spearheaded a commercialization strategy resulting in a successful financing and launch of new, revenue-generating products. Prior to FlexGen, Mr. Dom was CEO and Co-founder of RSP Technology BV, a world-leading supplier of aluminum superalloys to the defense, automotive, aerospace, and electronics industries based on a proprietary process exclusively licensed from Delft University. Dom began his career at Rijnvelden BV, focusing on investment in early-stage technology companies. He chairs the Dutch grant advisory committee to the Ministry of Economic Affairs in the field of innovation and entrepreneurship (total budget € 80 million) and he is a member of the “Regiegroep”—14 industrial and academic thought leaders in Dutch Life Science industry. This high-profile group is appointed by the Minister of Economic Affairs, to develop a new industry vision and recommend new policies to support the Dutch Life Science & Health industry (Topsectorplan). Mr. Dom holds a BSc and MSc from Erasmus University.
Follow Fred Dom:
About HiFiBiO: HiFiBiO provides proprietary single cell technologies for applications in drug and biomarker discovery and development.
Kenneth Lynard
Group Chief Financial Officer of Zentiva
Follow Kenneth Lynard:
About Zentiva: Zentiva develops and manufactures generic medicines providing the NHS with low cost alternatives to branded medicines.
David van Hoytema
CFO of Viroclinics Biosciences
Follow David van Hoytema:
About Birdseye Advisors, FastTrack Company, Viroclinics Biosciences: Viroclinics Biosciences is a contract research and clinical laboratory service company providing diagnostic and preclinical studies.
Karin de Jong
CFO of Fagron SA
Karin de Jong is the CFO of Fagron, a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Follow Karin de Jong:
About Fagron SA: Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Dennis Lammers
Chief Financial Officer of Khondrion
Dennis joined Khondrion as CFO in 2013. Dennis also holds a position as Financial Funding Affairs at the Technology Transfer Office at the Radboud University Medical Center, the Netherlands. He has extensive international experience in financial, project and business control as well as financial management of grants and cost price modeling.
Follow Dennis Lammers:
About Khondrion: Khondrion is a clinical-stage pharmaceutical company.
Leonard Kruimer
CFO of to-BBB
Follow Leonard Kruimer:
About to-BBB: The Company combines existing drugs with to-BBB’s proprietary G-Technology® for enhanced drug delivery across the blood-brain barrier.